A life-course and multifactorial approach to Alzheimer’s disease: Implications for research,clinical assessment and intervention practices

Abstract

According to the dominant biomedical view, Alzheimer’s disease (AD) has a precise, necessary and unifying neurobiological cause, which distinguishes it from other neurodegenerative diseases and normal ageing. However, different types of evidence specifically lead to questioning the foundations of this essentialist and category-based approach to AD. It seems more and more evident that AD represents a heterogeneous state, determined by multiple factors and mechanisms that interact and intervene throughout life. This other way of conceiving AD not only requires a change of research objectives, but also a profound modification of clinical assessment and intervention practices. It also appeals to follow the path of prevention.

Keywords

Alzheimer’s disease biomedical approach assessment intervention prevention

Get full access to this article

View all access options for this article.

References

Ahmed, R., Devenney, E. M., Irish, M., Ittner, A., Naismith, S., Ittner, L. M., …Kiernan, M. C. (2016). Neuronal network disintegration: Common pathways linking neurodegenerative diseases. Journal of Neurology, Neurosurgery & Psychiatry. 87, 1234–1241.

Andrews-Hanna, J. R., Snyder, A. Z., Vincent, J. L., Lustig, C., Head, D., Raichle, M. E., & Buckner, R. L. (2007). Disruption of large-scale brain systems in advanced aging. Neuron, 56, 924–935.

Barnes

D. E.

Yaffe

(2011) The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurology 10: 819–828.

Barnett

J. H.

Hachinski

Blackwell

A. D.

(2013) Cognitive health begins at conception: Addressing dementia as a lifelong and preventable condition. BMC Medicine 11: 246.

Beer

Ch.

Flicker

Horner

Bretland

Scherer

Nicola

Almeida

O. P.

(2010) Factors associated with self and informant ratings of the quality of life of people with dementia living in care facilities: A cross sectional study. PLoS ONE 5: e15621.

Blazer

D. G.

Yaffe

Liverman

C. T.

(2015) Cognitive aging. Progress in understanding and opportunities for action, Washington, DC: The National Academies Press.

Bozoki

A. C.

Bozoki

E. S.

Little

R. J.

(2009) The existence of cognitive plateaus in Alzheimer's disease. Alzheimer's & Dementia 5: 470–478.

Brayne

Davis

(2012) Making Alzheimer’s and dementia research fit for populations. Lancet 380: 1441–1443.

Brayne

Gao

Dewey

Matthews

F. E.

Medical Research Council Cognitive Function, Aging Study Investigators (2006) Dementia before death in ageing societies. The promise of prevention and the reality. PLoS Medicine 3: 1922–1929.

10.

Castellani

R. J.

Perry

(2012) Pathogenesis and disease-modifying therapy in Alzheimer’s disease: The flat line of progress. Archives of Medical Research 43: 694–698.

11.

Chen

Maleski

Sawmiller

D. R.

(2011) Scientific truth or false hope? Understanding Alzheimer‘s disease from an aging perspective. Journal of Alzheimer’s Disease 24: 3–10.

12.

Chételat

(2013) Aβ-independent processes: Rethinking preclinical AD. Nature Reviews/Neurology 9: 123–124.

13.

Clare

Linden

D. E. J.

Woods

R. T.

Evans

S. J.

Parkinson

C. H.

van Paasschen

Rugg

M. D.

(2010) Goal-oriented cognitive rehabilitation for people with early-stage Alzheimer disease: A single-blind randomized controlled trial of efficacy. American Journal of Geriatric Psychiatry 18: 928–939.

14.

Cooper

Mukadam

Katona

Lyketsos

C. G.

Blazer

Rabins

Livingston

(2013) Systematic review of the effectiveness of pharmacological interventions to improve quality of life and well-being in people with dementia. American Journal of Geriatric Psychiatry 21: 173–183.

15.

Deckers

van Boxel

M. P.

Schipers

O. J.

de Vugt

Munoz Sanchez

J. L.

Anstey

K. J.

Köhler

(2015) Target risk factors for dementia prevention: A systematic review and Delphi consensus study on the evidence from observational studies. International Journal of Geriatric Psychiatry 30: 234–246.

16.

Dugger

B. N.

Hentz

J. G.

Adler

C. H.

Sabbagh

M. N.

Shill

H. A.

Jacobson

Beach

T. G.

(2014) Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers. Journal of Neuropathology and Experimental Neurology 73: 244–252.

17.

Fjell

A. M.

McEvoy

Holland

Dale

A. M.

Walhovd

K. B.

(2014) What is normal in normal aging? Effects of aging, amyloid, and Alzheimer’s disease on the cerebral cortex and the hippocampus. Progress in Neurobiology 117: 20–40.

18.

Friedland

R. P.

Nandi

(2013) A modest proposal for a longitudinal study of dementia prevention (with apologies to Jonathan Swift, 1729). Journal of Alzheimer’s Disease 33: 313–315.

19.

Fotuhi

Hachinski

Whitehouse

(2009) Changing perspectives regarding late-life dementia. Nature Reviews Neurology 5: 649–658.

20.

Herrup

(2010) Reimagining Alzheimer’s disease. An age-based hypothesis. The Journal of Neuroscience 15: 16755–16762.

21.

Jellinger

K. A.

Attems

(2015) Challenge of multimorbidity of the aging brain: A critical update. Journal of Neural Transmission 122: 505–521.

22.

Kaduszkiewicz

Eisele

Wiese

Prokein

Luppa

Luck

Riedel-Heller

S. G.

(2014) Prognosis of mild cognitive impairment in general practice of the German AgeCoDe study. Annals of Family Medicine 12: 158–165.

23.

Katz

Calasanti

(2015) Critical perspectives on successful aging: Does it “appeal more than it illuminates”? Gerontologist 55: 26–33.

24.

Kinderman

(2005) A psychological model of mental disorder. Harvard Review of Psychiatry 13: 206–217.

25.

Kinderman

(2014) A prescription for psychiatry: Why we need a whole new approach to mental health and wellbeing, Basingstoke, UK: Palgrave Macmillan.

26.

Kinderman

(2015) Imagine there’s no diagnosis, it’s easy if you try. Psychopathology Review 2: 154–161.

27.

Kling

M. A.

Trojanowski

J. Q.

Wolk

D. A.

Lee

V. M.

Arnold

S. E.

(2013) Vascular disease and dementias: Paradigm shifts to drive research in new directions. Alzheimer’s & Dementia 9: 76–92.

28.

Larson

E. B.

Yaffe

Langa

K. M.

(2013) New insights into the dementia epidemic. The New England Journal of Medicine 369: 2275–2277.

29.

Lock

(2013) The Alzheimer’s conundrum. Entanglements of dementia and aging, Princeton, NJ: Princeton University Press.

30.

Mak

(2011) Self-reported goal pursuit and purpose in life among people with dementia. The Journals of Gerontology 66B: 177–184.

31.

Marcos

Santabàrbara

Lopez-Anton

De-la-Càmara

Gracia-Garcia

Lobo

(2016) Conversion to dementia in mild cognitive impairment diagnosed with DSM-5 criteria and with Petersen’s criteria. Acta Psychiatrica Scandinavica 133: 378–385.

32.

Matthews

F. E.

Stephan

B. C. M.

McKeith

I. G.

Bond

Brayne

, and the Medical Research Council Cognitive Function and Ageing Study (2008) Two-year progression from mild cognitive impairment to dementia: To what extent do different definitions agree? Journal of the American Geriatrics Society 56: 1424–1433.

33.

Mattsson

Rosén

Hansson

Andreasen

Parnetti

Jonsson

Zetterberg

(2012) Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology 78: 468–476.

34.

Miller

Z. A.

Mandelli

M. L.

Rankin

K. P.

Henry

M. L.

Babiak

M. C.

Frazier

D. T.

Gorno-Tempini

(2013) Handedness and language learning disability differentially distribute in progressive aphasia variants. Brain 136: 3461–3473.

35.

Mitchell

A. J.

Shiri-Feskhi

(2009) Rate of progression of mild cognitive impairment to dementia – Meta-analysis of 41 robust inception cohort studies. Acta Psychiatrica Scandinavica 119: 252–265.

36.

Mungas

Beckett

Harvey

Tomaszewski Farias

Reed

Carmichael

DeCarli

Ch.

(2010) Heterogeneity of cognitive trajectories in diverse older persons. Psychology and Aging 25: 606–619.

37.

Neill

(2012) Should Alzheimer’s disease be equated with human brain ageing? A maladaptive interaction between brain evolution and senescence. Ageing Research Reviews 11: 104–122.

38.

Ngandu

Lehtisalo

Solomon

Levälahti

Ahtiluoto

Antikainen

Kivipelto

(2015) A 2 year multidomain intervention of diet, exercice, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial. Lancet 385: 2255–2263.

39.

Nordström

Eriksson

Wahlund

L.-O.

Gustafson

(2013) Risk factors in late adolescence for young-onset dementia in men. A nation cohort study. JAMA Internal Medicine 173: 1612–1618.

40.

Park

D. C.

Rueter-Lorenz

P. A.

(2009) The adaptive brain: Aging and neurocognitive scaffolding. Annual Review of Psychology 60: 173–196.

41.

Power

A. G.

(2010) Dementia beyond drugs. Changing the culture of care, Baltimore: Health Professions Press.

42.

Reuter-Lorenz

P. A.

Park

D. C.

(2014) How does it STAC up? Revisiting the scaffolding theory of aging and cognition. Neuropsychological Review 24: 355–370.

43.

Richard

Schmand

Eikelenboom

Westendorp

R. G.

Van Gool

W. A.

(2012) The Alzheimer myth and biomarker research in dementia. Journal of Alzheimer’s Disease 31: S203–S209.

44.

Rowe

J. W.

Kahn

R. L.

(1998) Successful aging, New York, NY: Random House.

45.

Rowe

C. C.

Ellis

K. A.

Rimajova

Bourgeat

Pike

K. E.

Jones

Villemagne

V. L.

(2010) Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle study of aging. Neurobiology of Aging 31: 1275–1283.

46.

Satizabal

C. L.

Beiser

A. S.

Chouraki

Chêne

Dufouil

Seshadri

(2016) Incidence of dementia over three decades in the Framingham Heart Study. The New England Journal of Medicine 374: 523–531.

47.

Scheltens

A. M. E.

Galindo-Garre

Pijnenburg

Y. A.

van der Vlies

A. E.

Smits

L. L.

Koene

van der Flier

W. M.

(2016) The identification of cognitive subtypes in Alzheimer’s disease dementia using latent class analysis. Journal of Neurology, Neurosurgery and Psychiatry 87: 235–243.

48.

Schneider

L. S.

(2012) Could cholinesterase inhibitors be harmful overt the long term? International Psychogeriatrics 24: 171–174.

49.

Seifan

Assuras

Huey

E. D.

Mez

Tsapanou

Caccappolo

(2015) Childhood learning disabilities and atypical dementia: A retrospective chart review. PLOS One 10(6): e0129919.

50.

Sona

Zhang

Ames

Bush

A. I.

Lautenschlager

N. T.

Martins

R. N.

Ellis

K. A.

AIBL Research Group (2012) Predictors of rapid cognitive decline in Alzheimer’s disease: Results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of ageing. International Psychogeriatrics 24: 197–204.

51.

Song

Mitnitski

Zhang

Chen

Rockwood

for the Alzheimer’s Disease Neuroimaging Initiative (2013) Dynamics of brain structure and cognitive function in the Alzheimer’s disease neuroimaging initiative. Journal of Neurology, Neurosurgery, and Neuropsychiatry 84: 71–78.

52.

Stephan

B. C. M.

Kurth

Matthews

F. E.

Brayne

Dufouil

(2010) Dementia risk prediction in the population: Are screening models accurate? Nature Reviews Neurology 6: 318–326.

53.

Tricco

A. C.

Soobiah

Beliner

J. M.

C. H.

Ashoor

H. M.

Straus

S. E.

(2013) Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: A systematic review and meta-analysis. Canadian Medical Association Journal 185: 1393–1401.

54.

Tschanz

J. T.

Corcoran

Ch. D.

Schwartz

Treiber

Green

R. C.

Norton

M. C.

Rabins

P. V.

(2011) Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia. The Cache County Dementia Progression Study. American Journal of Geriatric Psychiatry 19: 532–542.

55.

Van der Linden

Juillerat Van der Linden

A.-C.

(2014a) Penser autrement le vieillissement, Bruxelles: Mardaga.

56.

Van der Linden

Juillerat Van der Linden

A.-C.

(2014b) L’évaluation neuropsychologique dans la démence: un changement d’approche. In: Seron

Van der Linden

(eds) Traité de neuropsychologie clinique de l’adulte, Paris: De Boeck-Solal, pp. 575–598.

57.

Ward

Tardiff

Dye

Arrighi

H. M.

(2013) Rate of conversion from prodromal Alzheimer’s disease to Alzheimer’s dementia: A systematic review of the literature. Dementia and Geriatric Cognitive Disorders Extra 3: 320–332.

58.

Walhovd

K. B.

Fjell

A. M.

Epseseth

(2014) Cognitive decline and brain pathology in aging – Need for a dimensional, lifespan and systems vulnerability view. Scandinavian Journal of Psychology 55: 244–254.

59.

Wharton

Brayne

Savva

Matthews

F. E.

Forster

Simpson

Ince

(2011) Epidemiological neuropathology: the MRC cognitive function and aging study experience. Journal of Alzheimer’s Disease 25: 359–372.

60.

Whitehouse

(2013a) The challenges of cognitive aging: Integrating approaches from science to intergenerational relationships. Journal of Alzheimer’s Disease 36: 225–232.

61.

Whitehouse

(2013b) The challenges of cognitive aging: Integrating approaches from science to intergenerational relationships. Journal of Intergenerational Relationships 11: 105–117.

62.

Whitehouse

George

(2008) The myth of Alzheimer's: What you aren't being told about today's most dreaded diagnosis, New York, NY: St Martin’s Press.

63.

Zeilig

(2013) Dementia as a cultural metaphor. The Gerontologist 54: 258–267.